Skip to main content

Guanabenz Pregnancy and Breastfeeding Warnings

Brand names: Wytensin

Guanabenz Pregnancy Warnings

Guanabenz has been assigned to pregnancy category C by the FDA. Some animal data have shown an increased incidence of fetal loss, neonatal mortality, and skeletal abnormalities after doses three to six times the maximum recommended human dose of 1 mg/kg were given. There are no controlled data in human pregnancy. Guanabenz should only be given during pregnancy when benefits outweighs risk.

See references

Guanabenz Breastfeeding Warnings

There are no data on the excretion of guanabenz into human milk. Because many drugs are excreted in human milk, the manufacturer recommends that caution should be exercised when guanabenz is administered to a nursing woman.

See references

See also

References for pregnancy information

  1. (2001) "Product Information. Wytensin (guanabenz)." Wyeth-Ayerst Laboratories

References for breastfeeding information

  1. (2001) "Product Information. Wytensin (guanabenz)." Wyeth-Ayerst Laboratories

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer